Jennifer Elliott
No más puestos en curso
Origen de la red de primer grado Jennifer Elliott.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.
2
| Holding Company | Biotechnology | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jennifer Elliott a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
OnKure, Inc.
 OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Biotechnology | Director/Board Member | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal | |
| Yale University | College/University | Corporate Officer/Principal | |
| The University of Colorado | College/University | Corporate Officer/Principal | |
| University of Groningen | College/University | Doctorate Degree | |
| University of Canterbury | College/University | Doctorate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
BiVACOR, Inc.
 BiVACOR, Inc. Medical SpecialtiesHealth Technology BiVACOR, Inc. develops and manufactures medical device. The firm specializes in rotary blood pumps, biomedical engineering. The company was founded by Daniel Timms in 2008 and is headquartered in Houston, TX. | Medical Specialties | Director/Board Member | |
| IMMUNEERING CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| C4 THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Expansion Therapeutics, Inc.
 Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | Pharmaceuticals: Major | Director/Board Member | |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Biotechnology | Founder | |
Cormorant Asset Management LLC/Private Equity/
 Cormorant Asset Management LLC/Private Equity/ Investment ManagersFinance Cormorant Asset Management LLC/Private Equity/ (Cormorant Asset Management) is a venture capital subsidiary of Cormorant Asset Management LP founded in 2013 by Bi Hua Chen. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Founder | |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
ONK Therapeutics Ltd.
 ONK Therapeutics Ltd. BiotechnologyHealth Technology ONK Therapeutics Ltd. develops bio cells for anti cancer therapies. The company was founded by Michael O'Dwyer and Anthony Killarney in 2015 and is headquartered in Galway, Ireland. | Biotechnology | Director/Board Member | |
| ELEVATION ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
Kestrel Therapeutics, Inc.
 Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kestrel Therapeutics, Inc. operates as a biotechnology development company. The company is based in Wayland, MA. The CEO of the company is Frank G. Haluska. | Miscellaneous Commercial Services | Director/Board Member | |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Cormorantasset Management LP | Corporate Officer/Principal | ||
| MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Blossom Biosciences Ltd.
 Blossom Biosciences Ltd. BiotechnologyHealth Technology Blossom Biosciences Ltd. provides molecular and cell biology research services. The company is based in Hong Kong, Hong Kong. Andrew J. Phillips has been the CEO of the Chinese company since 2021. | Biotechnology | Chief Executive Officer | |
| Aleksia Therapeutics, Inc. | Chief Executive Officer | ||
| Blossom Biomedicines USA, Inc. | Director/Board Member | ||
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Godfrey Huggins School of Medicine | College/University | Undergraduate Degree | |
| Klarman Cell Observatory | Director/Board Member | ||
Nexo Therapeutics, Inc.
 Nexo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nexo Therapeutics is a small molecule oncology company that focuses on discovering and developing new drugs for cancer patients who do not have effective treatments. The company is based in Littleton, CO and Watertown, MA. The company uses covalent ligand discovery, chemical biology, cancer biology, and medicinal chemistry to target the underlying causes of cancer through innovative methods. Nexo Therapeutics was founded by John Athanosopoulos, Andrew J. Phillips, Michael Kim, and Rhamy Zeid. Andrew J. Phillips has been the CEO of the company since 2022. | Pharmaceuticals: Major | Founder |
Estadísticas
Internacional
| Estados Unidos | 24 |
| Suiza | 3 |
| Países Bajos | 2 |
| Nueva Zelanda | 2 |
| Irlanda | 2 |
Sectorial
| Health Technology | 15 |
| Consumer Services | 7 |
| Finance | 4 |
| Commercial Services | 3 |
| Health Services | 2 |
Operativa
| Director/Board Member | 17 |
| Corporate Officer/Principal | 8 |
| Chief Executive Officer | 4 |
| President | 3 |
| Independent Dir/Board Member | 3 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Andrew Phillips | 23 |
| Ramnik Xavier | 11 |
- Bolsa de valores
- Insiders
- Jennifer Elliott
- Conexiones Empresas
